Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1998
12/09/1998EP0882085A1 Biodegradable polymer networks for use in orthopedic and dental applications
12/09/1998EP0881953A1 Electrostatic coating of small falling objects
12/09/1998EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/09/1998EP0881904A2 Topical pharmaceutical composition containing heparin
12/09/1998EP0881899A2 Dosage form of ibuprofen
12/09/1998EP0881891A1 Male contraceptive implant
12/09/1998EP0796088A4 Prevention of leakage during thermotropic phase transition in liposomes and biological cells
12/09/1998EP0767632A4 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof
12/09/1998EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN2299619Y 'Jinqian' ointment
12/09/1998CN1201397A Improved prescription for steroid compound administration
12/09/1998CN1201388A Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
12/09/1998CN1201387A Lyophilized thioxanthenone anti-tumor angents
12/09/1998CN1201386A Microemlsions used as carriers for administration of active compounds
12/09/1998CN1201385A Therapeutic preparation for transdermal administration of active substances
12/09/1998CN1201384A Aerosol compositions
12/09/1998CN1201033A Solid chemical compound, preparation method therefor and use in medicine
12/09/1998CN1200942A Interferon liposome jellies
12/09/1998CN1200941A Venereal disease preventing medicine containing interferon
12/09/1998CN1200936A Traditional Chinese medicine extract tablet and preparation method therefor
12/09/1998CN1200934A Lactobacillus ointment for treatment of vaginal diseases and preparation method therefor
12/09/1998CN1200926A Composition containing diflucortolone acetate butyrate
12/09/1998CN1200924A Fluoxetine enteric micropills
12/09/1998CN1200923A Method for making women's fluid multi-purpose safety protective cover
12/08/1998US5847206 Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications
12/08/1998US5847023 Thermal irreversible gel corneal contact lens formed in situ
12/08/1998US5847012 Microporous polymeric foams and microtextured surfaces
12/08/1998US5847010 Treatment of multiple sclerosis
12/08/1998US5847009 Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
12/08/1998US5846983 Colonic delivery of nicotine to treat inflammatory bowel disease
12/08/1998US5846960 Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds
12/08/1998US5846952 Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
12/08/1998US5846951 Pharmaceutical compositions
12/08/1998US5846947 Composition containing nucleic acids, preparation and uses
12/08/1998US5846930 Therapeutic human albumin having a low aluminium binding capacity
12/08/1998US5846595 Method of making pharmaceutical using electrostatic chuck
12/08/1998US5846568 Directly compressible lactitol and method
12/08/1998US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998US5846565 Controlled local delivery of chemotherapeutic agents for treating solid tumors
12/08/1998US5846564 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
12/08/1998US5846563 Sustained release heterodisperse hydrogel systems for insoluble drugs
12/08/1998US5846562 Oral composition of fumagillol derivative
12/08/1998US5846561 Method of binding collagen recognizing substances to liposomes
12/08/1998US5846559 Skin patch for use in contact immunotherapy
12/08/1998US5846558 Ionically conductive adhesives prepared from zwitterionic materials and medical devices using such adhesives
12/08/1998US5846557 Chewing gum containing cough suppressing agent
12/08/1998US5846556 Inhalant for reducing stress and method of use
12/08/1998US5846532 Method and composition for the treatment of disorders involving immunological dysfunction
12/08/1998US5846530 Macrocapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor
12/08/1998US5846521 Pressurized solvent-free drug aerosol compositions containing hydrofluorocarbon propellants
12/08/1998US5846516 Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
12/08/1998US5846458 Inhibition adsorption of proteins on the liposome surface
12/08/1998US5846058 Dental trays having thin walls for increased patient comfort
12/08/1998CA2140546C Patch for low-melting and/or volatile active substances
12/08/1998CA2108330C Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin
12/08/1998CA2073180C Therapeutic uses of melanin
12/08/1998CA2042289C Taste masking and sustained release coatings for pharmaceuticals
12/08/1998CA1340171C Aqueous solution conataing fat-soluble vitamin k
12/03/1998WO1998054821A1 Brush holder
12/03/1998WO1998054347A1 Integrin-targeting vectors having transfection activity
12/03/1998WO1998054271A1 Gelling agent and gel compositions
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998054130A1 Compounds, preparation and use for transferring nucleic acids into cells
12/03/1998WO1998053907A1 Betaine product, method for its manufacture, and its use
12/03/1998WO1998053863A2 Composition and methods for transdermal delivery of acid labile drugs
12/03/1998WO1998053847A1 Transdermal delivery system
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053844A1 Pharmaceutical compostions of peptides having low solubility in physiological medium
12/03/1998WO1998053837A1 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
12/03/1998WO1998053829A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
12/03/1998WO1998053828A1 Israpafant-containing water-base preparations
12/03/1998WO1998053825A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
12/03/1998WO1998053819A1 Therapeutic agent for erection failure
12/03/1998WO1998053815A1 Transdermal drug delivery device for the delivery of tropisetron or granisetron
12/03/1998WO1998053810A1 Pharmaceutical injection solution containing taxol
12/03/1998WO1998053808A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
12/03/1998WO1998053806A1 Medicinal compositions for topical administration containing vitamin d and vitamin k
12/03/1998WO1998053805A1 Clear, injectable formulation of an anesthetic compound
12/03/1998WO1998053803A1 Pharmaceutical formulation of omeprazole
12/03/1998WO1998053802A1 Multi-layered osmotic device
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998053799A2 Immunogenic compositions
12/03/1998WO1998053798A1 Solid pharmaceutical preparation
12/03/1998WO1998053797A2 Encapsulation of water insoluble active substances with an amphiphilic character
12/03/1998WO1998053795A1 Cosmetic and dermopharmaceutical compositions containing threonine or serine derivatives
12/03/1998WO1998053777A1 Solid state fluid delivery system
12/03/1998WO1998053698A1 Uses of oil bodies
12/03/1998DE19722831A1 New vehicle system comprising stable, ternary mixed micelles
12/03/1998DE19722405A1 Einkapseln von wasserunlöslichen Wirkstoffen mit amphiphilem Charakter Encapsulation of water-insoluble drugs with amphiphilic character
12/03/1998CA2528646A1 Solid pharmaceutical preparation
12/03/1998CA2297180A1 Solid state fluid delivery system
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291765A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/03/1998CA2291735A1 Israpafant-containing water-base preparations
12/03/1998CA2291335A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
12/03/1998CA2291261A1 Clear, injectable formulation of an anesthetic compound
12/03/1998CA2291256A1 Therapeutic agent for erection dysfunction
12/03/1998CA2289522A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
12/03/1998CA2288840A1 Integrin-targeting vectors having transfection activity